Heron Therapeutics Inc (HRTX)

EBITDA Growth

-184.58%

Quarterly · Period ending:

HRTX logo

HRTX EBITDA Growth

Year-over-year change vs the same period a year earlier

Latest reported-184.58%
HRTX Quarterly EBITDA YoY % (200.00% → -184.58%)
High-resolution chart · PNG

HRTX ebitda growth history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Heron Therapeutics Inc EBITDA Growth — Quarterly
Period endingEBITDA Growth
-50.0986%
-83.5196%
-225.2857%
-30.8824%
-269%
-179.5556%
-22.2222%
-197.1429%
-14.2857%
50%
350%
800%
450%
-33.3333%
128.5714%
93.3333%
85.7143%
169.2308%
54.8387%
16.6667%
17.6471%
-116.6667%
-121.4286%
33.3333%
32%
62.5%
44%
-12.5%
3.8462%
15.7895%
-31.5789%
-242.8571%
-225%
0%
-72.7273%
30%
-300%
-90%
-10%
9.0909%
77.7778%
-25%
9.0909%
-22.2222%
10%
-260%
86.0759%
-250%
-300%
-44.4444%
-54.902%
100%
25%
200%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.